TY - JOUR
T1 - TriMatch comparison of the efficacy of FloSeal versus TachoSil versus no hemostatic agents for partial nephrectomy
T2 - Results from a large multicenter dataset
AU - RECORd Project-LUNA Foundation
AU - Antonelli, Alessandro
AU - Minervini, Andrea
AU - Mari, Andrea
AU - Bertolo, Riccardo
AU - Bianchi, Giampaolo
AU - Lapini, Alberto
AU - Longo, Nicola
AU - Martorana, Giuseppe
AU - Mirone, Vincenzo
AU - Morgia, Giuseppe
AU - Novara, Giacomo
AU - Porpiglia, Francesco
AU - Rocco, Bernardo
AU - Rovereto, Bruno
AU - Schiavina, Riccardo
AU - Simeone, Claudio
AU - Sodano, Mario
AU - Terrone, Carlo
AU - Ficarra, Vincenzo
AU - Carini, Marco
AU - Serni, Sergio
N1 - Publisher Copyright:
© 2014 The Japanese Urological Association.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Objectives: To evaluate the efficacy of hemostatic agents, TachoSil and FloSeal, during partial nephrectomy using a large multicenter dataset. Methods: Data of 1055 patients who underwent partial nephrectomy between January 2009 and December 2012 in 19 Italian centers were collected within an observational multicentric study (RECORd Project). The decision whether or not to use hemostatic agents after renorrhaphy and the type of hemostatic agents applied was adopted according to the centers' and surgeons' preference. A TriMatch propensity score analysis was applied to balance three study groups (no hemostatic agents, TachoSil, FloSeal) for sex, age, surgical indication (elective/relative vs imperative), clinical stage (cT1avscT1b), tumor exophyticity, approach (open vs minimally invasive), technique (standard partial nephrectomy vs simple enucleation), preoperative hemoglobin and creatinine. Postoperative complications and variation of hemoglobin and creatinine values between preoperative versus third postoperative day were compared. Results: TriMatch analysis allowed us to obtain 66 well-balanced triplets. No differences were found in terms of outcomes between the study groups. Conclusions: The present findings suggest that adding hemostatic agents to renorraphy during partial nephrectomy does not provide better surgical outcomes.
AB - Objectives: To evaluate the efficacy of hemostatic agents, TachoSil and FloSeal, during partial nephrectomy using a large multicenter dataset. Methods: Data of 1055 patients who underwent partial nephrectomy between January 2009 and December 2012 in 19 Italian centers were collected within an observational multicentric study (RECORd Project). The decision whether or not to use hemostatic agents after renorrhaphy and the type of hemostatic agents applied was adopted according to the centers' and surgeons' preference. A TriMatch propensity score analysis was applied to balance three study groups (no hemostatic agents, TachoSil, FloSeal) for sex, age, surgical indication (elective/relative vs imperative), clinical stage (cT1avscT1b), tumor exophyticity, approach (open vs minimally invasive), technique (standard partial nephrectomy vs simple enucleation), preoperative hemoglobin and creatinine. Postoperative complications and variation of hemoglobin and creatinine values between preoperative versus third postoperative day were compared. Results: TriMatch analysis allowed us to obtain 66 well-balanced triplets. No differences were found in terms of outcomes between the study groups. Conclusions: The present findings suggest that adding hemostatic agents to renorraphy during partial nephrectomy does not provide better surgical outcomes.
KW - Bleeding
KW - Complications
KW - Hemostasis
KW - Hemostatic agent
KW - Partial nephrectomy
UR - http://www.scopus.com/inward/record.url?scp=84921001110&partnerID=8YFLogxK
U2 - 10.1111/iju.12603
DO - 10.1111/iju.12603
M3 - Article
SN - 0919-8172
VL - 22
SP - 47
EP - 52
JO - International Journal of Urology
JF - International Journal of Urology
IS - 1
ER -